Human Technopole continues its dialogue with Italian Research Hospitals (IRCCS).
Milan, 15 January – Human Technopole is an open hub for the entire Italian scientific community. This is how Marco Simoni – President of Human Technopole – described the Foundation during the event “Le strategie di ricerca della Fondazione Human Technopole: quali opportunità per gli IRCCS della Lombardia“, held at Palazzo Italia and organized by Assolombarda.
President Marco Simoni, Maria Grazia Magro (Head of Strategy and Scientific Affairs of Human Technopole) and Giuseppe Testa (Head of Neurogenomics Centre) explained the next steps of Human Technopole to almost 40 Research Hospitals’ General Director and Scientific Directors including Maria Chiara Carrozza (Scientific Director of Fondazione Don Gnocchi ), Alberto Mantovani (Scientific Director of Humanitas) and Fabrizio Tagliavini (Scientific Director of the Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta). Sergio Dompé – Vice President Life Sciences, Assolombarda – underlined Human Technopole’s innovative scope, its impact on Lombardy’s economic income and expressed the strong contribution that Assolombarda wants to give to the IRCCSs of Lombardy.
Human Technopole’s openness, its positive effects for the whole country and common objectives with the IRCCSs are the concepts stressed in Marco Simoni’s speech; Maria Grazia Magro highlighted the dialogue carried out with the representatives of the Italian scientific community in the past months when more than half of the Italian IRCCSs were met individually by Human Technopole. Giuseppe Testa focused on the work of his centre and on the synergies that can be implemented with the scientific community in the near future.
Yesterday, Open HT was announced – the first event organized by Human Technopole addressed to the scientific community, which will be the first, shared occasion of systematic dialogue on the Foundation’s development strategies.
Share:
You could also like:
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.
-
Human Technopole Foundation’s Supplier List online
The Human Technopole Foundation’s Supplier Register is now online.
-
HT Director Zerial Awarded Mercurio Prize for Excellence in Research
The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.
-
A new model system for cortical development in vitro
Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.
-
The National Facility for Genomics with Clelia Peano
Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.